Finoriq research workspace
DEXCOM INC (DXCM) Institutional Holdings & 13F Ownership
DEXCOM INC offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system. Review DXCM institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
- Company
- DEXCOM INC (DXCM)
- Ticker
- DXCM
- Market Cap
- $29.3B
- Latest Price
- $75.88
- Industry
- Medical Devices
DEXCOM INC (DXCM) Top Institutional Holders
Top current 13F holders indexed for DEXCOM INC (DXCM). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Ron BaronCIK 0001017918 | $15.1M | 0.05% | Filing2026-05-15 |
| 2 | Ken FisherCIK 0000850529 | $11.8M | 0.0% | Filing2026-05-05 |
| 3 | Ray DalioCIK 0001350694 | $8.8M | 0.04% | Filing2026-05-15 |
| 4 | Joel GreenblattCIK 0001510387 | $6.8M | 0.02% | Filing2026-05-15 |
| 5 | First Eagle Investment ManagementCIK 0001325447 | $3,642 | 0.0% | Filing2026-05-14 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.